Skip to content

Metagenomi Therapeutics, Inc.

MGX · XNAS

CIK 1785279fmd_1JKWDF0N1PAY4GYZ4JSTHRFB75Manufacturing · Biological Products, (No Diagnostic Substances)Template: Standard

Coverage: Jan 01, 2023 to Sep 30, 2026, 15 periods

News summary

An AI model writes the summary on request, from this company's recent filings only, and cites each filing it uses.

AI-written
0 filings

From 8-K filings, not wire news: the items each filer selected on the EDGAR cover, grouped by event type. Importance is FinancialMD's own rule by item number (5: bankruptcy, non-reliance, change of control, delisting, cybersecurity; 1: exhibits only).

Loading